Register entry
UBI Pharma Inc.
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- Taiwan
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| UBI Pharma Inc. | HukouTaiwan | Analytical testing, Finished drug manufacture, Packaging | 3004713402 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | INJECTION | ANDA |
| DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | INJECTION | ANDA |
| DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | INJECTION | ANDA |
| Olanzapine Intramuscular | Olanzapine | INJECTION, POWDER, FOR SOLUTION | ANDA |
| Voriconazole | voriconazole | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ANDA |
| leuprolide acetate | leuprolide acetate | KIT | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.